Ascend Laboratories, LLC recalls

14 recalls on record · latest: April 27, 2026

Official U.S. recall history for Ascend Laboratories, LLC, compiled from official government records.

Get recall alerts

Free email alert whenever Ascend Laboratories, LLC has a new recall — straight from official government data. Unsubscribe anytime.

Ascend Laboratories, LLC recalls Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem La…

April 27, 2026 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c)…

September 19, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877…

September 19, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c).…

September 19, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manu…

September 19, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Ascend Laboratories, LLC recalls Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distribut…

August 28, 2025 · Drug & medication recalls Moderate risk Superpotent drug

Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories…

July 21, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications: low dissolution results

Rizatriptan Benzoate Tablets recalled over manufacturing violations

July 9, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above th…

Rizatriptan Benzoate Tablets recalled over manufacturing violations

July 9, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above th…

Ascend Laboratories, LLC recalls Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories…

May 23, 2025 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications An out-of-specification result was…

Ascend Laboratories, LLC recalls Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories…

May 23, 2025 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications An out-of-specification result was…

Dabigatran Etexilate recalled over manufacturing violations

December 12, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended in…

Dabigatran Etexilate recalled over manufacturing violations

December 12, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended in…

Ascend Laboratories, LLC recalls Mycophenolic Acid Delayed-Release Tablets USP, 360 mg, Rx Only, 120 Tablets per bottle, Manufactured by Alkem Laborator…

September 3, 2024 · Drug & medication recalls Moderate risk Failed Dissolution Specifications